Integra LifeSciences Gets FDA Clearance For Integra Laminoplasty System

(RTTNews) - Integra LifeSciences Holdings Corp. (IART) has launched the Integra Laminoplasty System, a comprehensive set of implants and instruments designed for use after open-door laminoplasty procedures in the cervical and thoracic spine or C3-T3. This system, which has received 510(k) clearance from the U.S. Food and Drug Administration or FDA, would be featured at the North American Spine Society or NASS 28th annual meeting, October 9 - 12, 2013, in New Orleans, Louisiana.

The system incorporates several plate and screw options, enabling surgeons to treat varying patient anatomies. The user-friendly Integra Laminoplasty system consists of multiple plate insertion and drill guide options, and a new retentive screw driver, ensuring a seamless approach to laminoplasty procedures.

Laminoplasty procedures treat spinal stenosis by relieving pressure on the spinal cord, the company noted.